phase 3
ii 3
trial 4
evaluate 1
efficacy 1
fostamatinib 1
patients 3
relapsed 2
refractory 2
diffuse 2
large 3
bcell 2
lymphoma 8
dlbcl 1
ibrutinib 1
initial 1
therapy 1
chronic 1
lymphocytic 1
leukemia 1
evaluation 1
international 1
prognostic 2
score 2
ips 2
simpler 1
advanced 1
hodgkin 3
modern 2
era 2
outcomes 2
transformed 2
follicular 1
report 1
national 1
lymphocare 1
study 1
nlcs 1
intergroup 2
alisertib 1
peripheral 1
tcell 1
mycosis 1
fungoides 1
swog 1
gray 1
zone 1
features 1
intermediate 1
between 1
classical 1
characteristics 1
prognostication 1
among 1
multicenter 1
cohort 1
randomized 1
iii 1
comparing 1
abvd 1
plus 1
radiotherapy 1
stanford 1
v 1
regimen 1
stages 1
locally 1
extensive 1
bulky 1
mediastinal 1
subset 1
analysis 1
north 1
american 1
e 1
